NOX4 and cardiovascular disorder: As two isoforms of NAD(P)H oxidase, NOX2 and NOX4 are primary resources for ROSs in cardiovascular cells, and targeting NOX2 and/or NOX4 could be an important strategy for treating cardiovascular diseases [19,20].